Antigen presentation by endothelial cells: What role in the pathophysiology of malaria?

Trends in Parasitology

Volumn 28, Issue 4, 2012, Pages 151-160

  Razakandrainibe, Romy ^a   Pelleau, Stéphane ^b   Grau, Georges E ^c   Jambou, Ronan ^a  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b AIX MARSEILLE UNIVERSITY   (France)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antigen presentation; Dengue; Endothelial cell; Malaria

Indexed keywords

CD28 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EZRIN; FIBRIN; FOCAL ADHESION KINASE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEAT SHOCK PROTEIN 27; HLA DR ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OCCLUDIN; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL LYASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PROTEIN ZO1; RADIXIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR; VINCULIN;

ANTIGEN PRESENTATION; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN MALARIA; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL DISRUPTION; CELL INTERACTION; CELL MEMBRANE PERMEABILITY; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; HEMORRHAGIC FEVER; HUMAN; IMMUNOFLUORESCENCE; INNATE IMMUNITY; MACROPHAGE; MALARIA; NATURAL KILLER CELL; NEUTROPHIL COUNT; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PLASMODIUM YOELII INFECTION; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, PROTOZOAN; CELL MEMBRANE PERMEABILITY; ENDOTHELIAL CELLS; HUMANS; MALARIA; PLASMODIUM;

EID: 84859009528     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2012.01.004     Document Type: Review

References (99)

1. Jambou R., et al. Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions. PLoS Pathog. 2010, 6:e1001021.
2. Carvalho L.J. Murine cerebral malaria: how far from human cerebral malaria?. Trends Parasitol. 2010, 26:271-272.
3. Hunt N.H., et al. Murine cerebral malaria: the whole story. Trends Parasitol. 2010, 26:272-274.
4. Rénia L., et al. Cerebral malaria: in praise of epistemes. Trends Parasitol. 2010, 26:275-277.
5. Riley E.M., et al. Neuropathogenesis of human and murine malaria. Trends Parasitol. 2010, 26:277-278.
6. Stevenson M.M., et al. Cerebral malaria: human versus mouse studies. Trends Parasitol. 2010, 26:274-275.
7. Taylor-Robinson A.W. Validity of modelling cerebral malaria in mice: argument and counter argument. J. Neuroparasitol. 2010, 1:N100601.
8. White N.J., et al. The murine cerebral malaria phenomenon. Trends Parasitol. 2010, 26:11-15.
9. Pober J.S., et al. Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J. Exp. Med. 1983, 157:1339-1353.
10. Wagner C.R., et al. The mechanism of antigen presentation by endothelial cells. Immunobiology 1984, 168:453-469.
11. + allogeneic vascular endothelium. Identification of accessory interactions. Transplantation 1993, 56:128-134.
12. Mishto M., et al. Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains. Neurobiol. Aging 2006, 27:54-66.
13. Bagai R., et al. Mouse endothelial cells cross-present lymphocyte-derived antigen on class I MHC via a TAP1- and proteasome-dependent pathway. J. Immunol. 2005, 174:7711-7715.
14. Pentcheva H.T., et al. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 2004, 21:401-413.
15. Omari K.I., Dorovini-Zis K. Expression and function of the costimulatory molecules B7-1 (CD80) and B7-2 (CD86) in an in vitro model of the human blood-brain barrier. J. Neuroimmunol. 2001, 113:129-141.
16. Ragheb J.A., et al. CD28-Mediated regulation of mRNA stability requires sequences within the coding region of the IL-2 mRNA. J. Immunol. 1999, 163:120-129.
17. + T lymphocytes: a critical component of antitumor immunity. Cancer Invest. 2005, 23:413-419.
18. Brown D.M. Cytolytic CD4 cells: direct mediators in infectious disease and malignancy. Cell. Immunol. 2010, 262:89-95.
19. + cytotoxic T lymphocytes in the control of viral diseases and cancer. Int. Rev. Immunol. 2010, 29:371-402.
20. + T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J. Exp. Med. 2010, 207:637-650.
21. Smedsrod B. Clearance function of scavenger endothelial cells. Comp. Hepatol. 2004, 3(Suppl. 1):S22.
22. Knolle P.A., et al. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J. Immunol. 1999, 162:1401-1407.
23. + T cells results in antigen-specific T-cell tolerance. Nat. Med. 2000, 6:1348-1354.
24. Schurich A., et al. Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells. J. Immunol. 2010, 184:4107-4114.
25. + T-cell immunity. Gastroenterology 2010, 138:336-346.
26. Thomson A.W., Knolle P.A. Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 2010, 10:753-766.
27. Kolowos W., et al. Microparticles shed from different antigen-presenting cells display an individual pattern of surface molecules and a distinct potential of allogeneic T-cell activation. Scand. J. Immunol. 2005, 61:226-233.
28. Wassmer S.C., et al. Vascular endothelial cells cultured from patients with cerebral or uncomplicated malaria exhibit differential reactivity to TNF. Cell. Microbiol. 2011, 13:198-209.
29. Mfonkeu J.B., et al. Biochemical markers of nutritional status and childhood malaria severity in Cameroon. Br. J. Nutr. 2010, 104:886-892.
30. Combes V., et al. Cerebral malaria: role of microparticles and platelets in alterations of the blood-brain barrier. Int. J. Parasitol. 2006, 36:541-546.
31. Freyssinet J.M. Cellular microparticles: what are they bad or good for?. J. Thromb. Haemost. 2003, 1:1655-1662.
32. Combes V., et al. Microvesiculation and cell interactions at the brain-endothelial interface in cerebral malaria pathogenesis. Prog. Neurobiol. 2010, 91:140-151.
33. Perlmann P., et al. Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria. Infect. Immun. 1997, 65:116-121.
34. Mazier D., et al. Cerebral malaria and immunogenetics. Parasite Immunol. 2000, 22:613-623.
35. Pongponratn E., et al. Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am. J. Trop. Med. Hyg. 1991, 44:168-175.
36. Boonpucknavig V., et al. An immunofluorescence study of cerebral malaria. A correlation with histopathology. Arch. Pathol. Lab. Med. 1990, 114:1028-1034.
37. Genrich G.L., et al. Fatal malaria infection in travelers: novel immunohistochemical assays for the detection of Plasmodium falciparum in tissues and implications for pathogenesis. Am. J. Trop. Med. Hyg. 2007, 76:251-259.
38. Combes V., et al. Circulating endothelial microparticles in Malawian children with severe falciparum malaria complicated with coma. JAMA 2004, 291:2542-2544.
39. Combes V., et al. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am. J. Pathol. 2005, 166:295-302.
40. Faille D., et al. Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J. 2009, 23:3449-3458.
41. Taylor T.E., et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med. 2004, 10:143-145.
42. + T cells in experimental cerebral malaria. J. Immunol. 2002, 169:6369-6375.
43. + T cells and IFN-gamma mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS ONE 2011, 6:e18720.
44. + T cells to the brain during Plasmodium berghei-mediated cerebral malaria. J. Immunol. 2007, 178:5779-5788.
45. + T cells induced by sporozoites and those induced by blood-stage Plasmodium berghei ANKA involved in the development of cerebral malaria. Infect. Immun. 2004, 72:2817-2826.
46. Mongkolsapaya J., et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 2003, 9:921-927.
47. Zivna I., et al. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J. Immunol. 2002, 168:5959-5965.
48. Dufour J.H., et al. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 2002, 168:3195-3204.
49. Mallevaey T., et al. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis. Infect. Immun. 2007, 75:2171-2180.
50. Gonzalez-Aseguinolaza G., et al. Alpha-galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8461-8466.
51. Soulard V., et al. Primary infection of C57BL/6 mice with Plasmodium yoelii induces a heterogeneous response of NKT cells. Infect. Immun. 2007, 75:2511-2522.
52. Barbier M., et al. Platelets alter gene expression profile in human brain endothelial cells in an in vitro model of cerebral malaria. PLoS ONE 2011, 6:e19651.
53. Jenkins N., et al. Plasmodium falciparum intracellular adhesion molecule-1-based cytoadherence-related signaling in human endothelial cells. J. Infect. Dis. 2007, 196:321-327.
54. Nguyen A., et al. Role of CaMKII in hydrogen peroxyde activation of ERK1/2, P-38 MAPK, HSP27 and actin reorganization in endothelial cells. FEBS Lett. 2004, 572:307-313.
55. Lee S.J., et al. ICAM-1-induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. J. Immunol. 2000, 165:4658-4666.
56. Turowski P., et al. Pharmacological targeting of ICAM-1 signaling in brain endothelial cells: potential for treating neuroinflammation. Cell. Mol. Neurobiol. 2005, 25:153-170.
57. Etienne-Manneville S., et al. ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines. J. Immunol. 2000, 165:3375-3383.
58. Susomboon P., et al. Down-regulation of tight junction mRNAs in human endothelial cells co-cultured with Plasmodium falciparum-infected erythrocytes. Parasitol. Int. 2006, 55:107-112.
59. Xie H., et al. Role of RhoA/ROCK signaling in endothelial-monocyte-activating polypeptide II opening of the blood-tumor barrier: role of RhoA/ROCK signaling in EMAP II opening of the BTB. J. Mol. Neurosci. 2011, 10.1007/s12031-011-9564-9.
60. Gillrie M.R., et al. Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins. Blood 2007, 110:3426-3435.
61. Treeratanapiboon L., et al. In vitro study of malaria parasite induced disruption of blood-brain barrier. Biochem. Biophys. Res. Commun. 2005, 335:810-818.
62. Krishnegowda G., et al. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 2005, 280:8606-8616.
63. Coban C., et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 2005, 201:19-25.
64. Coban C., et al. Manipulation of host innate immune responses by the malaria parasite. Trends Microbiol. 2007, 15:271-278.
65. Watts C., et al. TLR signalling regulated antigen presentation in dendritic cells. Curr. Opin. Immunol. 2010, 22:124-130.
66. Zanoni I., Granucci F. Regulation of antigen uptake, migration, and lifespan of dendritic cell by Toll-like receptors. J. Mol. Med. (Berl.) 2010, 88:873-880.
67. Blander J.M. Phagocytosis and antigen presentation: a partnership initiated by Toll-like receptors. Ann. Rheum. Dis. 2008, 67(Suppl. 3):iii44-iii49.
68. Kawai T., Akira S. TLR signaling. Cell Death Differ. 2006, 13:816-825.
69. Fitzgerald K.A., Chen Z.J. Sorting out Toll signals. Cell 2006, 125:834-836.
70. Kordes M., et al. Caspase-1 activation of interleukin-1β (IL-1β) and IL-18 is dispensable for induction of experimental cerebral malaria. Infect. Immun. 2011, 79:3633-3641.
71. Rock K.L., et al. Protein degradation and the generation of MHC class I-presented peptides. Adv. Immunol. 2002, 80:1-70.
72. Belicha-Villanueva A., et al. What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?. Immunol. Res. 2010, 46:32-44.
73. O'Keefe G.M., et al. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein. J. Immunol. 2001, 166:2260-2269.
74. Rock K.L., Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 2005, 207:166-183.
75. Cresswell P. Antigen processing and presentation. Immunol. Rev. 2005, 207:5-7.
76. Mach B., et al. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 1996, 14:301-331.
77. Ting J.P., Trowsdale J. Genetic control of MHC class II expression. Cell 2002, 109(Suppl):S21-S33.
78. Zhou F. Molecular mechanisms of viral immune evasion proteins to inhibit MHC class I antigen processing and presentation. Int. Rev. Immunol. 2009, 28:376-393.
79. Fruh K., Yang Y. Antigen presentation by MHC class I and its regulation by interferon gamma. Curr. Opin. Immunol. 1999, 11:76-81.
80. Vincent M.S., et al. Understanding the function of CD1-restricted T cells. Nat. Immunol. 2003, 4:517-523.
81. Renukaradhya G.J., et al. Virus-induced inhibition of CD1d1-mediated antigen presentation: reciprocal regulation by p38 and ERK. J. Immunol. 2005, 175:4301-4308.
82. Yamaguchi H., et al. Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: roles of protein kinase C-delta. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2095-2101.
83. Brutkiewicz R.R., et al. Protein kinase C d is a critical regulator of CD1d-mediated antigen presentation. Eur. J. Immunol. 2007, 37:2390-2395.
84. Kanlaya R., et al. Alterations in actin cytoskeletal assembly and junctional protein complexes in human endothelial cells induced by dengue virus infection and mimicry of leukocyte transendothelial migration. J. Proteome Res. 2009, 8:2551-2562.
85. Green S., Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr. Opin. Infect. Dis. 2006, 19:429-436.
86. Liu I.J., et al. Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J. Biol. Chem. 2011, 286:9726-9736.
87. Lin C.F., et al. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J. Immunol. 2002, 169:657-664.
88. Avirutnan P., et al. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol. 1998, 161:6338-6346.
89. Lin C.F., et al. Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J. Immunol. 2005, 174:395-403.
90. Talavera D., et al. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J. Gen. Virol. 2004, 85:1801-1813.
91. Vouret-Craviari V., et al. Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. Mol. Biol. Cell 1998, 9:2639-2653.
92. Schmidt M., et al. A role for rho-kinase in rho-controlled phospholipase D stimulation by the m3 muscarinic acetylcholine receptor. J. Biol. Chem. 1999, 274:14648-14654.
93. Liao H., et al. FasL/Fas pathway is involved in dengue virus induced apoptosis of the vascular endothelial cells. J. Med. Virol. 2010, 82:1392-1399.
94. He P. Leucocyte/endothelium interactions and microvessel permeability: coupled or uncoupled?. Cardiovasc. Res. 2010, 87:281-290.
95. Savage C.O. Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. Clin. Exp. Immunol. 2011, 164(Suppl. 1):23-26.
96. Day C.J., et al. New developments in the pathogenesis of ANCA-associated vasculitis. Clin. Exp. Rheumatol. 2003, 21:S35-S48.
97. + T cells in ANCA-associated systemic vasculitis. Nephrology (Carlton) 2009, 14:26-32.
98. Millington T.M., Madsen J.C. Innate immunity and cardiac allograft rejection. Kidney Int. 2010, (Suppl.):S18-S21.
99. Uehara S., et al. Further evidence that NK cells may contribute to the development of cardiac allograft vasculopathy. Transplant. Proc. 2005, 37:70-71.